Related Experiment Video

Updated: Aug 30, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumococcal disease in childhood

P V Mohan1, P T Heath

  • 1Paediatric Infectious Disease Unit, St George's Hospital, London SW17 0RE.

Hospital Medicine (London, England : 1998)
|August 2, 2001
PubMed

Insights

Streptococcus pneumoniae causes severe childhood infections globally. New pneumococcal conjugate vaccines show promise for routine infant immunization, addressing antibiotic resistance concerns.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Streptococcus pneumoniae is a leading cause of serious bacterial infections in children worldwide.
  • Increasing antibiotic resistance necessitates updated treatment guidelines for pneumococcal disease.
  • The emergence of drug-resistant S. pneumoniae strains poses a significant public health challenge.

Purpose of the Study:

  • To evaluate the impact of antibiotic resistance on treatment policies for pediatric pneumococcal infections.
  • To assess the efficacy of pneumococcal conjugate vaccines.
  • To inform decisions regarding the inclusion of pneumococcal vaccines in routine infant vaccination schedules.

Main Methods:

  • Review of current antibiotic resistance data for Streptococcus pneumoniae.
  • Analysis of clinical trial data demonstrating the efficacy of pneumococcal conjugate vaccines.
  • Evaluation of public health recommendations and vaccination policies.

Main Results:

  • Antibiotic resistance in Streptococcus pneumoniae has led to revised treatment strategies for children.
  • Pneumococcal conjugate vaccines have demonstrated significant efficacy in preventing pneumococcal disease.
  • Vaccine efficacy data supports consideration for widespread infant immunization.

Conclusions:

  • Updated antibiotic policies are crucial for managing pediatric pneumococcal infections due to resistance.
  • Pneumococcal conjugate vaccines represent a key strategy in controlling S. pneumoniae infections.
  • Routine infant vaccination with pneumococcal conjugate vaccines is recommended to combat disease burden and resistance.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...